G1 THERAPEUTICS INC's ticker is GTHX and the CUSIP is 3621LQ109. A total of 94 filers reported holding G1 THERAPEUTICS INC in Q1 2018. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2024 | $86,581 | -91.7% | 20,042 | -94.1% | 0.00% | -85.7% |
| Q4 2023 | $1,039,391 | +2299.0% | 340,784 | +1858.5% | 0.01% | – |
| Q2 2023 | $43,326 | -96.2% | 17,400 | -81.0% | 0.00% | -100.0% |
| Q3 2022 | $1,142,000 | +232.0% | 91,523 | +539.9% | 0.01% | +150.0% |
| Q1 2021 | $344,000 | -19.8% | 14,302 | +74.3% | 0.00% | -78.9% |
| Q3 2018 | $429,000 | -2.9% | 8,205 | -31.2% | 0.02% | -42.4% |
| Q1 2018 | $442,000 | – | 11,919 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MPM BioImpact LLC | 1,423,794 | $34,541,000 | 9.18% |
| Burrage Capital Management LLC | 373,876 | $9,070,000 | 6.35% |
| Birchview Capital, LP | 40,000 | $970,000 | 0.59% |
| 361 CAPITAL LLC | 47,325 | $1,148,000 | 0.54% |
| Rhenman & Partners Asset Management AB | 190,000 | $4,609,000 | 0.50% |
| CHI Advisors LLC | 44,000 | $1,067,000 | 0.42% |
| Bellevue Group AG | 721,925 | $17,514,000 | 0.25% |
| Candriam S.C.A. | 870,423 | $21,117,000 | 0.22% |
| Virtus ETF Advisers LLC | 18,991 | $461,000 | 0.22% |
| HHLR ADVISORS, LTD. | 949,431 | $23,033,000 | 0.21% |